WINT logo

Windtree Therapeutics (WINT) Operating Expenses

Annual Operating Expenses

$17.54 M
-$4.35 M-19.87%

31 December 2023

WINT Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$4.74 M
-$6.71 M-58.60%

30 September 2024

WINT Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

WINT Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.9%+1.1%
3 y3 years-42.1%-41.8%
5 y5 years-2.5%-34.0%

WINT Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-45.6%at low-58.6%+37.1%
5 y5 years-45.6%at low-58.6%+37.1%
alltimeall time-60.5%+1152.8%-70.9%+1285.3%

Windtree Therapeutics Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$4.74 M(-58.6%)
June 2024
-
$11.45 M(+160.0%)
Mar 2024
-
$4.41 M(-11.2%)
Dec 2023
$17.54 M(-19.9%)
$4.96 M(+5.7%)
Sept 2023
-
$4.69 M(+12.1%)
June 2023
-
$4.18 M(+12.8%)
Mar 2023
-
$3.71 M(+7.2%)
Dec 2022
$21.89 M(-32.1%)
$3.46 M(-17.6%)
Sept 2022
-
$4.20 M(-28.9%)
June 2022
-
$5.90 M(-29.2%)
Mar 2022
-
$8.33 M(+12.0%)
Dec 2021
$32.26 M(+6.4%)
$7.44 M(-8.7%)
Sept 2021
-
$8.15 M(+7.3%)
June 2021
-
$7.59 M(-16.4%)
Mar 2021
-
$9.08 M(+30.4%)
Dec 2020
$30.32 M(+20.8%)
$6.96 M(-20.0%)
Sept 2020
-
$8.71 M(+9.5%)
June 2020
-
$7.95 M(+18.6%)
Mar 2020
-
$6.70 M(+47.2%)
Dec 2019
$25.09 M(+39.5%)
$4.55 M(-36.6%)
Sept 2019
-
$7.19 M(+8.0%)
June 2019
-
$6.65 M(-0.7%)
Mar 2019
-
$6.70 M(+29.9%)
Dec 2018
$17.98 M(-25.2%)
$5.16 M(+39.4%)
Sept 2018
-
$3.70 M(-9.5%)
June 2018
-
$4.09 M(-19.0%)
Mar 2018
-
$5.04 M(+40.1%)
Dec 2017
$24.03 M(-40.0%)
$3.60 M(-25.2%)
Sept 2017
-
$4.81 M(-34.0%)
June 2017
-
$7.29 M(-12.6%)
Mar 2017
-
$8.34 M(+14.7%)
Dec 2016
$40.08 M(+0.5%)
$7.27 M(-16.4%)
Sept 2016
-
$8.69 M(-13.9%)
June 2016
-
$10.10 M(-28.0%)
Mar 2016
-
$14.02 M(+34.3%)
Dec 2015
$39.89 M(-8.1%)
$10.44 M(+22.6%)
Sept 2015
-
$8.51 M(-19.1%)
June 2015
-
$10.51 M(+0.7%)
Mar 2015
-
$10.44 M(-9.3%)
Dec 2014
$43.42 M(-2.2%)
$11.51 M(+8.6%)
Sept 2014
-
$10.60 M(-6.3%)
June 2014
-
$11.30 M(+12.9%)
Mar 2014
-
$10.01 M(+1.9%)
Dec 2013
$44.38 M(+16.7%)
$9.82 M(-9.7%)
Sept 2013
-
$10.87 M(-1.1%)
June 2013
-
$10.99 M(-13.4%)
Mar 2013
-
$12.69 M(+0.6%)
Dec 2012
$38.01 M(+51.5%)
$12.62 M(+26.2%)
Sept 2012
-
$10.00 M(+13.4%)
June 2012
-
$8.82 M(+34.0%)
Mar 2012
-
$6.58 M(+11.5%)
Dec 2011
$25.09 M(-1.7%)
$5.90 M(-4.3%)
Sept 2011
-
$6.17 M(-6.2%)
June 2011
-
$6.58 M(+2.2%)
Mar 2011
-
$6.44 M(+6.8%)
Dec 2010
$25.53 M(-12.6%)
$6.03 M(-2.8%)
Sept 2010
-
$6.20 M(-0.4%)
June 2010
-
$6.23 M(-11.8%)
Mar 2010
-
$7.07 M(+19.7%)
DateAnnualQuarterly
Dec 2009
$29.20 M(-32.1%)
$5.90 M(-15.0%)
Sept 2009
-
$6.95 M(-9.1%)
June 2009
-
$7.64 M(-12.2%)
Mar 2009
-
$8.70 M(+5.0%)
Dec 2008
$42.99 M(+7.6%)
$8.29 M(-20.7%)
Sept 2008
-
$10.45 M(-16.5%)
June 2008
-
$12.52 M(+6.6%)
Mar 2008
-
$11.74 M(-3.6%)
Dec 2007
$39.95 M(-5.1%)
$12.18 M(+30.5%)
Sept 2007
-
$9.33 M(-9.0%)
June 2007
-
$10.26 M(+25.5%)
Mar 2007
-
$8.18 M(+2.9%)
Dec 2006
$42.10 M(-1.3%)
$7.95 M(+0.2%)
Sept 2006
-
$7.93 M(-20.2%)
June 2006
-
$9.94 M(-39.0%)
Mar 2006
-
$16.30 M(+27.3%)
Dec 2005
$42.64 M(+9.0%)
$12.80 M(+22.0%)
Sept 2005
-
$10.49 M(+5.4%)
June 2005
-
$9.96 M(+6.1%)
Mar 2005
-
$9.39 M(-21.7%)
Dec 2004
$39.12 M(+53.6%)
$11.99 M(+39.8%)
Sept 2004
-
$8.58 M(-10.1%)
June 2004
-
$9.55 M(+6.2%)
Mar 2004
-
$8.99 M(+1.7%)
Dec 2003
$25.47 M(+28.6%)
$8.84 M(+36.7%)
Sept 2003
-
$6.47 M(+25.7%)
June 2003
-
$5.15 M(+2.7%)
Mar 2003
-
$5.01 M(-12.1%)
Dec 2002
$19.80 M(+51.5%)
$5.70 M(+11.6%)
Sept 2002
-
$5.11 M(-2.9%)
June 2002
-
$5.26 M(+40.7%)
Mar 2002
-
$3.74 M(-18.2%)
Dec 2001
$13.07 M(+2.4%)
$4.57 M(+72.2%)
Sept 2001
-
$2.65 M(-12.5%)
June 2001
-
$3.03 M(+7.7%)
Mar 2001
-
$2.82 M(-60.2%)
Dec 2000
$12.76 M(+137.3%)
$7.08 M(+216.1%)
Sept 2000
-
$2.24 M(-10.9%)
June 2000
-
$2.51 M(+63.9%)
Mar 2000
-
$1.53 M(+20.0%)
Dec 1999
$5.38 M(-32.8%)
$1.28 M(+41.9%)
Sept 1999
-
$900.00 K(-25.0%)
June 1999
-
$1.20 M(-40.0%)
Mar 1999
-
$2.00 M(+5.3%)
Dec 1998
$8.00 M(+29.0%)
$1.90 M(+46.2%)
Sept 1998
-
$1.30 M(-45.8%)
June 1998
-
$2.40 M(+4.3%)
Mar 1998
-
$2.30 M(-50.0%)
Dec 1997
$6.20 M(+342.9%)
$4.60 M(+1050.0%)
Sept 1997
-
$400.00 K(-82.6%)
June 1997
-
$2.30 M(+666.7%)
Mar 1997
-
$300.00 K(-175.0%)
Dec 1996
$1.40 M(-51.7%)
-$400.00 K(-150.0%)
Sept 1996
-
$800.00 K(+100.0%)
June 1996
-
$400.00 K(-20.0%)
Mar 1996
-
$500.00 K(0.0%)
Dec 1995
$2.90 M
-
June 1995
-
$500.00 K(+400.0%)
Mar 1995
-
$100.00 K

FAQ

  • What is Windtree Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Windtree Therapeutics?
  • What is Windtree Therapeutics annual operating expenses year-on-year change?
  • What is Windtree Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Windtree Therapeutics?
  • What is Windtree Therapeutics quarterly operating expenses year-on-year change?

What is Windtree Therapeutics annual total operating expenses?

The current annual operating expenses of WINT is $17.54 M

What is the all time high annual operating expenses for Windtree Therapeutics?

Windtree Therapeutics all-time high annual total operating expenses is $44.38 M

What is Windtree Therapeutics annual operating expenses year-on-year change?

Over the past year, WINT annual total operating expenses has changed by -$4.35 M (-19.87%)

What is Windtree Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of WINT is $4.74 M

What is the all time high quarterly operating expenses for Windtree Therapeutics?

Windtree Therapeutics all-time high quarterly total operating expenses is $16.30 M

What is Windtree Therapeutics quarterly operating expenses year-on-year change?

Over the past year, WINT quarterly total operating expenses has changed by +$51.00 K (+1.09%)